Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.

[1]  Upendra Nagaich.  Recent advances in ocular drug delivery system , 2014, Journal of advanced pharmaceutical technology & research.

[2]  J. Majoral,et al.  Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry , 2013 .

[3]  K. Saroha,et al.  SUSTAINED RELEASE DRUG DELIVERY SYSTEM: AN OVERVIEW , 2012 .

[4]  Nikolaos Pandis,et al.  The effect size. , 2012, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[5]  Christina Graf,et al.  Multivalency as a chemical organization and action principle. , 2012, Angewandte Chemie.

[6]  R. Einspanier,et al.  Glycine-terminated dendritic amphiphiles for nonviral gene delivery. , 2012, Biomacromolecules.

[7]  R. Haag,et al.  Polyether based amphiphiles for delivery of active components , 2012 .

[8]  R. Haag,et al.  Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. , 2012, Chemical Society reviews.

[9]  R. Saneto,et al.  Current oral and non-oral routes of antiepileptic drug delivery. , 2012, Advanced drug delivery reviews.

[10]  Emanuel Fleige,et al.  Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.

[11]  Chelsea E T Stowell,et al.  Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration. , 2012, Biomacromolecules.

[12]  Scott C. Brown,et al.  Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy , 2012, International journal of nanomedicine.

[13]  H. Ghandehari,et al.  Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery. , 2012, Advanced drug delivery reviews.

[14]  Yanjun Zhao,et al.  Dendrimer-mediated drug delivery to the skin , 2012 .

[15]  Jayant Khandare,et al.  Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. , 2012, Chemical Society reviews.

[16]  L. Kaminskas,et al.  Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation. , 2012, Molecular pharmaceutics.

[17]  J. Majoral,et al.  Dendrimer therapeutics: covalent and ionic attachments , 2012 .

[18]  Krishna R. Raghupathi,et al.  Stimuli Sensitive Amphiphilic Dendrimers. , 2012, New journal of chemistry = Nouveau journal de chimie.

[19]  J. Lam,et al.  Pulmonary delivery of therapeutic siRNA , 2011, Advanced Drug Delivery Reviews.

[20]  C. RanaA.,et al.  ORAL SUSTAINED RELEASE DRUG DELIVERY SYSTEM: AN OVERVIEW , 2012 .

[21]  R. Iezzi,et al.  Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. , 2012, Biomaterials.

[22]  J. Sirc,et al.  Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[23]  R. Haag,et al.  Degradable self-assembling dendrons for gene delivery: experimental and theoretical insights into the barriers to cellular uptake. , 2011, Journal of the American Chemical Society.

[24]  R. Duncan,et al.  Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.

[25]  N. K. Jain,et al.  The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates. , 2011, Biomaterials.

[26]  D. Owen,et al.  Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[27]  M. Hildreth,et al.  Structure-Skin Permeability Relationship of Dendrimers , 2011, Pharmaceutical Research.

[28]  N. K. Jain,et al.  Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate. , 2011, Journal of pharmaceutical sciences.

[29]  H. Katsumi,et al.  Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats. , 2011, Journal of pharmaceutical sciences.

[30]  S. Wołowiec,et al.  Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. , 2011, International journal of pharmaceutics.

[31]  R. Williams,et al.  Influence of particle size on regional lung deposition--what evidence is there? , 2011, International journal of pharmaceutics.

[32]  Shinobu Fujii,et al.  Recent Advances in Ocular Drug Delivery Systems , 2011 .

[33]  H. Katsumi,et al.  Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[34]  F. Szoka,et al.  Chemotherapeutic Evaluation of a Synthetic Tubulysin Analogue–Dendrimer Conjugate in C26 Tumor Bearing Mice , 2011, ChemMedChem.

[35]  J. Khandare,et al.  Polymer-Drug Conjugates: Recent Achievements. , 2011 .

[36]  R. Thakur,et al.  Modern Delivery Systems for Ocular Drug Formulations: A Comparative Overview W.R.T Conventional Dosage Form , 2011 .

[37]  Mark W Grinstaff,et al.  Biomedical applications of dendrimers: a tutorial. , 2011, Chemical Society reviews.

[38]  S. Kawakami,et al.  Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations , 2011, Pharmaceutical Research.

[39]  F. Ahmad,et al.  Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics , 2010, Indian journal of pharmaceutical sciences.

[40]  Hak Soo Choi,et al.  Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.

[41]  R. Kannan,et al.  In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation. , 2010, International journal of pharmaceutics.

[42]  Marek Pyda,et al.  PAMAM dendrimers as solubilizers and hosts for 8-methoxypsoralene enabling transdermal diffusion of the guest. , 2010, International journal of pharmaceutics.

[43]  A. Caminade,et al.  Biological properties of phosphorus dendrimers , 2010 .

[44]  W. Hörl.  Nonsteroidal Anti-Inflammatory Drugs and the Kidney , 2010, Pharmaceuticals.

[45]  H. Katsumi,et al.  Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats. , 2010, International journal of pharmaceutics.

[46]  S. Kannan,et al.  Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates. , 2010, Biomaterials.

[47]  Y. Pei,et al.  PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex , 2010, Journal of drug targeting.

[48]  J. Stobaugh,et al.  Bioanalytical method development for a generation 5 polyamidoamine folic acid methotrexate conjugated nanoparticle , 2010, Analytical and bioanalytical chemistry.

[49]  É. Boisselier,et al.  Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. , 2010, Chemical reviews.

[50]  D. Shabat,et al.  Self-immolative dendrimers: A distinctive approach to molecular amplification , 2010 .

[51]  C. Kojima.  Design of stimuli-responsive dendrimers , 2010, Expert opinion on drug delivery.

[52]  R. Kannan,et al.  Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.

[53]  J. Kopeček,et al.  HPMA copolymers: origins, early developments, present, and future. , 2010, Advanced drug delivery reviews.

[54]  H. Ghandehari,et al.  HPMA copolymer-cyclic RGD conjugates for tumor targeting. , 2010, Advanced drug delivery reviews.

[55]  S. Miller,et al.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases. , 2010, Advanced drug delivery reviews.

[56]  M. Vicent,et al.  Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities. , 2010, Advanced drug delivery reviews.

[57]  K. Ulbrich,et al.  HPMA copolymers: 30 years of advances. , 2010, Advanced drug delivery reviews.

[58]  H. Moghimi,et al.  Reduction of percutaneous absorption of toxic chemicals by dendrimers , 2010, Cutaneous and ocular toxicology.

[59]  M. J. Santander-Ortega,et al.  Nanoparticles made from novel starch derivatives for transdermal drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[60]  A. Caminade,et al.  Designing dendrimers for ocular drug delivery. , 2010, European journal of medicinal chemistry.

[61]  N. K. Jain,et al.  Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice , 2010, Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[62]  A. Höke,et al.  Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies , 2009, Expert opinion on drug discovery.

[63]  E. Doris,et al.  Recent advances in the field of nanometric drug carriers. , 2009, Future medicinal chemistry.

[64]  N. K. Jain,et al.  Dendrimers as therapeutic agents: a systematic review , 2009 .

[65]  Rishi Paliwal,et al.  Nanocarriers in ocular drug delivery: an update review. , 2009, Current pharmaceutical design.

[66]  F. Szoka,et al.  Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. , 2009, Molecular pharmaceutics.

[67]  C. Setty,et al.  Chemical Penetration Enhancers for Transdermal Drug Delivery Systems , 2009 .

[68]  Venkata Vamsi K Venuganti,et al.  Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration. , 2009, Journal of pharmaceutical sciences.

[69]  T. Patterson,et al.  Overview of antifungal agents. , 2009, Clinics in chest medicine.

[70]  Narendra Kumar Jain,et al.  Dendrimers in oncology: an expanding horizon. , 2009, Chemical reviews.

[71]  Tobias Blaschke,et al.  Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[72]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[73]  Jim Jiao.  Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. , 2008, Advanced drug delivery reviews.

[74]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[75]  Prateek Singh,et al.  Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. , 2008, Bioconjugate chemistry.

[76]  Omathanu Perumal,et al.  Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. , 2008, International journal of pharmaceutics.

[77]  N. K. Jain,et al.  Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability , 2008, Expert opinion on drug metabolism & toxicology.

[78]  M. Grinstaff,et al.  Therapeutic and diagnostic applications of dendrimers for cancer treatment. , 2008, Advanced drug delivery reviews.

[79]  P. Choyke,et al.  Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. , 2008, Molecular pharmaceutics.

[80]  P. Swaan,et al.  Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers , 2008, Pharmaceutical Research.

[81]  Abhay Asthana,et al.  Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient , 2005, AAPS PharmSciTech.

[82]  T. Xu,et al.  Dendrimers as drug carriers: applications in different routes of drug administration. , 2008, Journal of pharmaceutical sciences.

[83]  Shuhua Bai,et al.  Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. , 2007, Journal of pharmaceutical sciences.

[84]  Xu Tongwen,et al.  Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. , 2007 .

[85]  Shelton D Caruthers,et al.  Nanotechnological applications in medicine. , 2007, Current opinion in biotechnology.

[86]  D. Tomalia,et al.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. , 2007, Biochemical Society transactions.

[87]  Xiaomin Wang,et al.  Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. , 2007, Journal of pharmaceutical sciences.

[88]  F. Szoka,et al.  A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas , 2006, Proceedings of the National Academy of Sciences.

[89]  H. Sheardown,et al.  Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions. , 2006, Biomaterials.

[90]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[91]  M J Hawkins,et al.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[92]  C. Lemere,et al.  Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice , 2006, Journal of Neuroinflammation.

[93]  Shi Yunyu,et al.  Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies. , 2006, European journal of medicinal chemistry.

[94]  Felix Kratz,et al.  Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.

[95]  U. Kompella,et al.  Nanoparticles for Ocular Drug Delivery , 2006 .

[96]  E. W. Meijer,et al.  Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes) , 2006, Journal of drug targeting.

[97]  R. Satchi‐Fainaro,et al.  Polymer therapeutics for cancer : Current status and future challenges , 2006 .

[98]  P. Dobbin,et al.  Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy. , 2006, The international journal of biochemistry & cell biology.

[99]  S. Factor,et al.  Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression , 2006, Journal of Neuroinflammation.

[100]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[101]  A. Schätzlein,et al.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. , 2005, Cancer research.

[102]  T. Mccarthy,et al.  Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. , 2005, Molecular pharmaceutics.

[103]  Thommey P. Thomas,et al.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. , 2005, Cancer research.

[104]  Hidetoshi Arima,et al.  Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates , 2005 .

[105]  N. K. Jain,et al.  Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. , 2005, International journal of pharmaceutics.

[106]  Samir Mitragotri,et al.  Design principles of chemical penetration enhancers for transdermal drug delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Robert A Freitas,et al.  What is nanomedicine? , 2005, Disease-a-month : DM.

[108]  Francis C Szoka,et al.  Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. , 2005, Molecular pharmaceutics.

[109]  T. Vandamme,et al.  Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[110]  Narendra Kumar Jain,et al.  Solubility Enhancement of Indomethacin with Poly(amidoamine) Dendrimers and Targeting to Inflammatory Regions of Arthritic Rats , 2004, Journal of drug targeting.

[111]  M. Ciesielski,et al.  Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[112]  Istvan Toth,et al.  Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. , 2004, Experimental eye research.

[113]  B. Finnin,et al.  The transdermal revolution. , 2004, Drug discovery today.

[114]  Ruth Duncan,et al.  Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation , 2004, Nature Biotechnology.

[115]  Seungpyo Hong,et al.  Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. , 2004, Bioconjugate chemistry.

[116]  Antony D'Emanuele,et al.  Transport of dendrimer nanocarriers through epithelial cells via the transcellular route. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[117]  Antony D'Emanuele,et al.  The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[118]  Neil B. McKeown,et al.  Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity , 2003, Pharmaceutical Research.

[119]  Ruth Duncan,et al.  Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System? , 2000, Pharmaceutical Research.

[120]  M. Chatterjee,et al.  Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. , 2004, Bioconjugate chemistry.

[121]  H. Ghandehari,et al.  Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. , 2003, International journal of pharmaceutics.

[122]  M. Brechbiel,et al.  Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[123]  L. Vannucci,et al.  Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. , 2003, International journal of oncology.

[124]  S Sridevi,et al.  Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[125]  Manouchehr Mirshahi,et al.  Efficacy of dendrimer‐mediated angiostatin and TIMP‐2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies , 2003, International journal of cancer.

[126]  S. Jain,et al.  A PEGylated dendritic nanoparticulate carrier of fluorouracil. , 2003, International journal of pharmaceutics.

[127]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[128]  F. Hirayama,et al.  In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer. , 2003, Bioconjugate chemistry.

[129]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[130]  R. Wiwattanapatapee,et al.  Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[131]  Yoshihisa Nakano,et al.  Mechanism of enhancement effect of dendrimer on transdermal drug permeation through polyhydroxyalkanoate matrix. , 2003, Journal of bioscience and bioengineering.

[132]  Yoshihisa Nakano,et al.  Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer. , 2003, Journal of bioscience and bioengineering.

[133]  M. Caligiuri,et al.  Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. , 2002, Cancer research.

[134]  Ju-Hyun Kim,et al.  Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. , 2002, International journal of pharmaceutics.

[135]  S. Jain,et al.  Dendrimer grafts for delivery of 5-fluorouracil. , 2002, Die Pharmazie.

[136]  C. Pinilla,et al.  Targeting approaches to oral drug delivery , 2002, Expert opinion on biological therapy.

[137]  Kathy Wilkinson,et al.  Liposomal doxorubicin. , 2002, Clinical journal of oncology nursing.

[138]  K Togashi,et al.  Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[139]  J. Polli,et al.  Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. , 2001, International journal of pharmaceutics.

[140]  K. Kono,et al.  Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.

[141]  Y. Kalia,et al.  Transdermal drug delivery: overcoming the skin's barrier function. , 2000, Pharmaceutical science & technology today.

[142]  C. Ramachandran,et al.  Transdermal delivery of drugs for the treatment of bone diseases. , 2000, Advanced drug delivery reviews.

[143]  M. Rymaszewski,et al.  Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. , 2000, Human gene therapy.

[144]  N. Weiner,et al.  Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. , 2000, Biomaterials.

[145]  A T Florence,et al.  Oral uptake and translocation of a polylysine dendrimer with a lipid surface. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[146]  R. Duncan,et al.  Dendrimer-platinate: a novel approach to cancer chemotherapy. , 1999, Anti-cancer drugs.

[147]  I. Toth,et al.  Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. , 1999, International journal of pharmaceutics.

[148]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[149]  R. Barth,et al.  Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. , 1997, Cancer research.

[150]  D. Notterman,et al.  Alternative routes of drug administration - Advantages and disadvantages (subject review) , 1997 .

[151]  F. Pugliese,et al.  Nonsteroidal anti-inflammatory drugs (NSAIDs) and the kidney. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[152]  R. Duncan,et al.  Polymer Conjugates , 1994 .

[153]  R. Barth,et al.  Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. , 1994, Bioconjugate chemistry.

[154]  H. Pitkow,et al.  Basic and Clinical Pharmacology , 1983 .